Ashland Global Holdings Inc. offers specialized chemical solutions globally. The company is headquartered in Covington, Kentucky.
159 articles
Franklin Templeton disclosed a 5.6% beneficial ownership stake in Ashland Inc. through its investment management clients, holding over 2.5 million shares with voting rights managed by Franklin Mutual
Ashland Global Holdings Inc. announced its fourth-quarter fiscal 2026 earnings release for November 3, 2026, with a webcast on November 4 featuring CEO Guillermo Novo and CFO William Whitaker.
Ashland Inc. provides an overview of financials and analyst estimates on TradingView. Users can explore reported financial data and compare actual results with average, high, and low estimates.
Ashland Global Holdings Inc scheduled its fiscal third-quarter earnings report for November 4, 2026. Sales rose 7% to $497 million, though adjusted EBITDA declined year-over-year.
UBS reduced its price target for Ashland Global Holdings Inc to USD 80.00, despite the stock trading at USD 71.31 with a 2.00 percent dividend yield.
Ashland Global Holdings Inc has received updated analyst insights and price targets from major financial institutions such as UBS and Morgan Stanley. The report outlines recent stock upgrades and down
Ashland Global Holdings Inc shares rose 3% following reports that private equity firms and Clariant submitted initial bids for a potential sale amid activist investor pressure.
Ashland Global Holdings reported Q2 2026 EPS of $0.91, missing estimates, with revenue below consensus. It anticipates 18.16% earnings growth next year, scheduling Q4 results for November 3, 2026.
Ashland Inc. director Sanat Chattopadhyay acquired 212 Common Stock Units on September 30, 2026, under the Deferred Compensation Plan, bringing his total balance to 2,407 units.
Ashland director Steven D. Bishop purchased 368 common stock units at $67.92 each under the Deferred Compensation Plan, increasing his total holdings to 6,123 units.
Ashland Global Holdings Inc. released a detailed profile for its 6.875% bond maturing in 2043. The document outlines issuer business segments, bond terms, and credit risk assessment.
Ashland Global Holdings shares rose 30% in six months, outperforming the industry due to cost reductions and portfolio optimization. The firm prioritizes high-value specialty ingredients and innovatio
Ashland Inc. launched agrimer eco-disperse OD TVO, a crop-protection dispersant derived from transformed vegetable oil. The sustainable product offers biodegradable, microplastic-free solutions for no
Ashland Inc. extended its European receivables securitization program to September 2029 with a €125 million limit, appointing Bank of America Europe DAC as the new Committed Purchaser.
Ashland Global Holdings Inc presented its innovation strategy and technology platforms during its Innovation Day 2026 webcast. The event highlighted science-driven solutions driving scalable growth an
Ashland Global Holdings Inc submitted a Form 4 filing on September 23, 2026, disclosing changes in beneficial ownership by insiders as reported by Investing.com.
Ashland's SVP and CTO Musa Osama M converted 10,418 restricted stock units into common shares at $69.06 per share, with 3,647 shares withheld for taxes, raising direct holdings to 37,577.
Ashland Inc. globally launched Agrimer Eco-Disperse OD TVO, a vegetable oil-derived polymeric dispersant for crop protection formulations designed to prevent settling and nozzle clogging while remaini
Ashland Global Holdings has launched agrimer eco-disperse OD, a biodegradable, microplastic-free polymeric dispersant derived from transformed vegetable oils designed for non-aqueous crop protection f
Ashland Inc. launched agrimer™ eco-disperse OD, a new polymeric dispersant based on its Transformed Vegetable Oils technology. This nature-based product targets sustainable non-aqueous crop protection
Ashland Inc. will host an Innovation Day webcast on September 17, 2026, featuring leadership updates on technology platforms and commercial progress. Attendees can engage in a moderated Q&A session wi
Ashland Global Holdings Inc will host a virtual Innovation Day on September 17, 2026, presenting technology platforms and commercial progress aimed at driving organic growth.
Ashland has commercially launched permexa sodium caprate, an intestinal permeation enhancer for oral peptide and biologic drug products. The excipient supports oral alternatives to injectable therapie
Ashland Inc. launched Permexa sodium caprate, an intestinal permeation enhancer for oral peptide and biologic drugs such as GLP-1 agonists. This excipient aims to improve formulation consistency and s
Ashland has launched permexa™ sodium caprate, an intestinal permeation enhancer designed to facilitate the oral delivery of peptides and biologics such as GLP-1 agonists. This excipient aims to improv
Ashland Inc. received a Moderate Buy consensus from twelve brokerages with a $73.90 average price target, supported by high institutional ownership and a quarterly dividend.
Massachusetts Financial Services filed an amended Schedule 13G disclosing a 4.5% beneficial ownership stake in Ashland Inc., holding over 2 million shares as of June 30, 2026.
Omega Advisors increased its stake in specialty materials firm Ashland Inc by 1.215 million shares, though analyst models suggest the stock remains 9% overvalued despite strong financial health scores
Ashland Inc. has announced updates to its Board of Directors' committee assignments for new directors Allen A. Spizzo and Peter T. Thomas, effective August 7, 2026.
An analyst suggests Ashland Global Holdings Inc., a chemicals maker, could be valued at $90 per share in a potential takeover. The company is considering a sale following received takeover interest.
ChemBrief